MCM
AGN

Matarin Capital Management’s Allergan plc AGN Stock Holding History

Matarin Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,657
Closed -$239K – 171
2013
Q3 		$239K Hold
1,657
– – 0.2% 149
2013
Q2 		$209K Buy
+1,657
New +$188K 0.21% 154

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Matarin Capital Management's AGN Position: Q4 2013 in Review

Matarin Capital Management sold out of Allergan plc (AGN) in Q4 2013, closing a stake of 1,657 shares — an estimated $239K sold.

Matarin Capital Management first reported a position in AGN in Q2 2013 and held it in 2 quarters. The position peaked at $239K in Q3 2013. 552 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • Matarin Capital Management reported no remaining Allergan plc position as of Q4 2013 after selling out during the quarter.
  • Matarin Capital Management sold 1,657 Allergan plc shares in Q4 2013, an estimated $239K.
  • Matarin Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 2 quarters.
  • Matarin Capital Management's Allergan plc position peaked at $239K in Q3 2013.
  • 552 funds tracked by Wall St. Rank held Allergan plc as of Q4 2013.

Based on Matarin Capital Management's 13F filing for Q4 2013, filed 29 Jan 2014.